Cargando…
3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
Understanding the effects induced by carcinogens on primary colonic epithelial cells and how to counteract them might help to prevent colon cancer, which is one of the most frequent and aggressive cancers. In this study, we exposed primary human colonic epithelial cells (HCoEpC) to Benzo[a]pyrene (B...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948646/ https://www.ncbi.nlm.nih.gov/pubmed/35336037 http://dx.doi.org/10.3390/pharmaceutics14030663 |
_version_ | 1784674703119482880 |
---|---|
author | Santarelli, Roberta Pompili, Chiara Gilardini Montani, Maria Saveria Evangelista, Lorenzo Gonnella, Roberta Cirone, Mara |
author_facet | Santarelli, Roberta Pompili, Chiara Gilardini Montani, Maria Saveria Evangelista, Lorenzo Gonnella, Roberta Cirone, Mara |
author_sort | Santarelli, Roberta |
collection | PubMed |
description | Understanding the effects induced by carcinogens on primary colonic epithelial cells and how to counteract them might help to prevent colon cancer, which is one of the most frequent and aggressive cancers. In this study, we exposed primary human colonic epithelial cells (HCoEpC) to Benzo[a]pyrene (B[a]P) and found that it led to an increased production of pro-inflammatory cytokines and activated ERK1/2 and mTOR. These pathways are known to be involved in inflammatory bowel disease (IBD), which represents a colon cancer risk factor. Moreover, B[a]P reduced autophagy and mitophagy, processes whose dysregulation has been clearly demonstrated to predispose to cancer either by in vitro or in vivo studies. Interestingly, all the effects induced by B[a]P could be counteracted by 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol, H), the most powerful anti-inflammatory and antioxidant compound contained in olive oil. This study sheds light on the mechanisms that could be involved in colon carcinogenesis induced by a chemical carcinogen and identifies a safe natural product that may help to prevent them. |
format | Online Article Text |
id | pubmed-8948646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89486462022-03-26 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells Santarelli, Roberta Pompili, Chiara Gilardini Montani, Maria Saveria Evangelista, Lorenzo Gonnella, Roberta Cirone, Mara Pharmaceutics Article Understanding the effects induced by carcinogens on primary colonic epithelial cells and how to counteract them might help to prevent colon cancer, which is one of the most frequent and aggressive cancers. In this study, we exposed primary human colonic epithelial cells (HCoEpC) to Benzo[a]pyrene (B[a]P) and found that it led to an increased production of pro-inflammatory cytokines and activated ERK1/2 and mTOR. These pathways are known to be involved in inflammatory bowel disease (IBD), which represents a colon cancer risk factor. Moreover, B[a]P reduced autophagy and mitophagy, processes whose dysregulation has been clearly demonstrated to predispose to cancer either by in vitro or in vivo studies. Interestingly, all the effects induced by B[a]P could be counteracted by 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol, H), the most powerful anti-inflammatory and antioxidant compound contained in olive oil. This study sheds light on the mechanisms that could be involved in colon carcinogenesis induced by a chemical carcinogen and identifies a safe natural product that may help to prevent them. MDPI 2022-03-17 /pmc/articles/PMC8948646/ /pubmed/35336037 http://dx.doi.org/10.3390/pharmaceutics14030663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Santarelli, Roberta Pompili, Chiara Gilardini Montani, Maria Saveria Evangelista, Lorenzo Gonnella, Roberta Cirone, Mara 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells |
title | 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells |
title_full | 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells |
title_fullStr | 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells |
title_full_unstemmed | 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells |
title_short | 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells |
title_sort | 3,4-dihydroxyphenylethanol (dpe or hydroxytyrosol) counteracts erk1/2 and mtor activation, pro-inflammatory cytokine release, autophagy and mitophagy reduction mediated by benzo[a]pyrene in primary human colonic epithelial cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948646/ https://www.ncbi.nlm.nih.gov/pubmed/35336037 http://dx.doi.org/10.3390/pharmaceutics14030663 |
work_keys_str_mv | AT santarelliroberta 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells AT pompilichiara 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells AT gilardinimontanimariasaveria 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells AT evangelistalorenzo 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells AT gonnellaroberta 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells AT cironemara 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells |